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Abstract
Background: Whole cells are usually employed for biocatalytic reduction reactions to ensure
efficient coenzyme regeneration and to avoid problems with enzyme purification and stability. The
efficiency of whole cell-catalyzed bioreduction is frequently restricted by pronounced toxicity of
substrate and/or product to the microbial cells and in many instances the use of two-phase reaction
systems can solve such problems. Therefore, we developed new, biphasic reaction systems with
biocompatible water-immiscible ionic liquids (ILs) as alternatives to conventional organic solvents,
in order to improve the asymmetric reduction of 4-(trimethylsilyl)-3-butyn-2-one (TMSB) to (S)-4-
(trimethylsilyl)-3-butyn-2-ol {(S)-TMSBOL}, a key intermediate for synthesis of 5-lipoxygenase
inhibitors, using immobilized Candida parapsilosis CCTCC M203011 cells as the biocatalyst.
Results: Various ILs exerted significant but different effects on the bioreduction. Of all the tested
water-immiscible ILs, the best results were observed with 1-butyl-3-methylimidazolium
hexafluorophosphate (C4MIM·PF6), which exhibited not only good biocompatibility with the cells
but also excellent solvent properties for the toxic substrate and product, thus markedly improving
the efficiency of the bioreduction and the operational stability of the cells as compared to the IL-
free aqueous system. 2-Propanol was shown to be the most suitable co-substrate for coenzyme
regeneration, and it was found that the optimum volume ratio of buffer to C4MIM·PF6, substrate
concentration, buffer pH, 2-propanol concentration and reaction temperature were 4/1 (v/v), 24
mM, 5.5, 130 mM and 30°C, respectively. Under these optimized conditions, the maximum yield
and the product e.e. wer 97.7% and >99%, respectively, which are much higher than the
corresponding values previously reported. The efficient whole-cell biocatalytic process was shown
to be feasible on a 250-mL scale.
Conclusion: The whole cell-catalyzed asymmetric reduction of TMSB to (S)-TMSBOL can be
substantially improved by using a C4MIM·PF6/buffer biphasic system instead of a single-phase
aqueous system and the resulting biocatalytic process appears to be effective and competitive on a
preparative scale.
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Background
Enantiopure chiral alcohols have proved to be versatile
intermediates for the synthesis of many chiral pharmaceu-
ticals, agrochemicals, liquid crystals and flavors [1,2]. As
the silicon counterparts of chiral alcohols, enantiopure
silicon-containing alcohols are becoming increasingly
attractive, in that these silicon-containing compounds
play an important role not only in asymmetric synthesis
and functional materials, but also in the preparation of
silicon-containing drugs [3,4], such as Zifrosilone [5], Cis-
obitan [6] and TAC-101{4-[3,5-bis(trimethylsilyl)benza-
mido]benzoic acid} [7]. Such silicon-containing
molecules generally have greater pharmaceutical activity,
higher selectivity and lower toxicity than their carbon
counterparts. The enantiopure organosilicon compound
(S)-4-(trimethylsilyl)-3-butyn-2-ol {(S)-TMSBOL} is a
crucial intermediate for the synthesis of 5-lipoxygenase
inhibitors [8] for which there is an increasing demand.
For economic, environmental and social reasons, produc-
tion of (S)-TMSBOL via biocatalytic asymmetric reduction
of the corresponding prochiral 4-(trimethylsilyl)-3-butyn-
2-one (TMSB) would be an advantageous alternative to
traditional chemical synthesis. Whole microbial cells
rather than isolated enzymes would be preferable as the
biocatalysts to avoid the need for enzyme purification and
coenzyme addition, or the requirement for an additional
system for coenzyme regeneration. Also, enzyme inactiva-
tion is frequently less of a problem when the enzyme is
kept within the natural environments of living cells.
To our knowledge, only one attempt has been made so far
to carry out the asymmetric reduction of TMSB to (S)-
TMSBOL with an isolated enzyme, where yield (78%) and
product e.e. (57%) were both relatively low [9], possibly
due to the low activity and enantioselectivity of the
enzyme, as well as possible inhibition of the reaction by
substrate and product. Until recently, there has to our
knowledge been no report of whole cell-mediated asym-
metric reduction of TMSB to enantiopure (S)-TMSBOL.
Recently we screened a large number of microbial strains
for this reaction, including yeasts (Candida parapsilosis
CCTCC M203011, Rhodotorula  sp. AS2.2241, Candida
tropicalis, Saccharomyces cerevisiae, Trigonopsis variabilis),
bacteria (Lactobacillus brevis, Bacterium anthracoides) and a
mold (Geotrichum candidum) [10]. It was found that Can-
dida parapsilosis CCTCC M203011, a highly potent carbo-
nyl reductase-producing organism capable of effectively
catalyzing the stereoselective reduction of a variety of
prochiral ketones [11,12], was the best strain tested for
efficient synthesis of (S)-TMSBOL via asymmetric reduc-
tion of TMSB, in terms of the relatively high yield (81.3%)
and the excellent product e.e. (>99.9%). However, when
the bioreduction was conducted in an aqueous monopha-
sic system, high percentage yield was obtained only when
the substrate concentration was = 3 mM [10], due to pro-
nounced substrate and product inhibition of the reaction
at higher concentrations. Furthermore, the substrate
TMSB is unstable and liable to cleavage into a carbonyl
alkyne and trimethylhydroxysilane in aqueous medium.
Such cleavage of the substrate can be minimised by
decreasing the pH of the aqueous buffer, but this strategy
may result in the inactivation of microbial cells. Poor
aqueous solubility of hydrophobic ketone substrates may
also be a problem in such reactions [13].
In order to overcome these limitations a biphasic system
has been developed, where an aqueous buffer contains
the microbial cells and a water-immiscible organic phase
acts as a reservoir for substrate and product [14-16]. How-
ever, use of conventional organic solvents in such proc-
esses may be problematic because in many cases they are
toxic to the microbial cells. Also, they may be explosive
and are usually environmentally harmful. Hydrophobic
ionic liquids (ILs) are a promising new class of alternative
'green' solvents that are obvious candidates for a great
variety of biocatalytic transformations [17-21]. Many
kinds of ILs have proven to be biocompatible with effi-
cient biotransformations catalysed by diverse microbial
cells, including Saccharomyces cerevisiae,  Escherichia coli,
Geotrichum candidum,  Rhodotorula  sp. AS2.2241, Pichia
membranaefaciens  Hansen ZJPH07 and Lactobcillus kefir
[21-27], since Cull et al [28] first reported successful use of
the IL 1-butyl-3-methylimidazolium hexafluorophos-
phate (C4MIM·PF6) in a biphasic system for the hydroly-
sis of 1, 3-dicyanobenzene catalyzed by Rhodococcus R312
cells. To date, no report has been published on biocataly-
sis with whole cells of Candida parapsilosis CCTCC
M203011 in IL-containing systems.
In the present study, we have for the first time utilized var-
ious water-immiscible ILs in a two-phase system to
improve the biocatalytic asymmetric reduction of TMSB
to (S)-TMSBOL, catalyzed by immobilized Candida parap-
silosis  CCTCC M203011 cells (Fig. 1). In this system,
TMSB is reduced to enantiopure (S)-TMSBOL while con-
verting NAD(P)H to NAD(P)+, and the co-substrate 2-pro-
panol is simultaneously oxidized to acetone, thus driving
the reduction reaction by regenerating NAD(P)H from
NAD(P)+.
Results and discussion
Up to now, there have been a number of reports on bio-
catalytic reduction of ketones using microbial cells in var-
ious IL-containing reaction systems, where the catalytic
performances exhibited by the biocatalysts were closely
related to the cation and anion types of ILs, and the effect
of various ILs on the biocatalytic reactions has been found
to vary widely [25,27,29-31]. Therefore, we initially per-
formed asymmetric reduction of TMSB to (S)-TMSBOL,
catalyzed by immobilized Candida parapsilosis CCTCCBMC Biotechnology 2009, 9:90 http://www.biomedcentral.com/1472-6750/9/90
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M203011 cells, in various IL-based biphasic systems in
order to focus on the influence that the cations and the
anions of the various ILs had on the bioreduction (Table
1). A variety of ILs were chosen to allow exploration of a
range of anionic and cationic moieties. In order to allow
efficient use in the biotransformation reaction, ILs were
chosen that were liquid at 30°C [23], had density greater
than 1.2 g/cm3 (to allow effective separation of the phases
after the reaction) [23] and when water-saturated had a
viscosity of less than 400 mm2/s (in order to minimize
mass transfer limitations).
It was noted that the Candida parapsilosis CCTCC
M203011 cells were capable of catalyzing the asymmetric
reduction of TMSB in the various IL-based biphasic sys-
tems with a high product e.e. of above 99%. For the bipha-
sic systems involving CnMIM·PF6 (n  = 4-7), both the
initial reaction rate and the maximum yield clearly
decreased with the elongation of the alkyl chain (i.e.
increasing  n  value) of the IL cation, possibly partly
because of the increase in viscosity of the IL with increas-
ing n value [20,25,32], which may lead to a decrease of
substrate and product mass transfer rate between the two
phases. Alternatively, both the slightly lower partition
coefficients of TMSB and TMSBOL between IL and buffer
(Table 2) and the lower biocompatibility of IL with Cand-
ida parapsilosis CCTCC M203011 cells (Fig. 2) with
increasing n value could explain this observation. As indi-
cated in Fig. 2, the cell viability was clearly reduced in the
presence of substrate as compared to its absence in all the
reaction systems, especially in the aqueous monophasic
system, implying that the substrate and/or product
exerted a substantial toxicity to Candida parapsilosis
CCTCC M203011 cells. In comparison with IL-based
The bioreduction of TMSB to (S)-TMSBOL with immobilized Candida parapsilosis CCTCC M203011 cells in water-immiscible IL/ buffer biphasic systems Figure 1
The bioreduction of TMSB to (S)-TMSBOL with immobilized Candida parapsilosis CCTCC M203011 cells in 
water-immiscible IL/buffer biphasic systems.
Table 1: Effect of various water-immiscible ILs on the bioreduction
Medium Viscosity of IL
(cP, 30°C)
Vo
a
(μmol/min gcwm)
Yieldb
(%)
e.e.c
(%)
Aqueous buffer - 1.18d 33.6d >99d
C4MIM·PF6/buffer 173 1.56 85.0 >99
C5MIM·PF6/buffer 240 1.41 81.2 >99
C6MIM·PF6/buffer 312 1.30 77.4 >99
C7MIM·PF6/buffer 355 1.23 72.3 >99
iC4MIM·PF6/buffer 238 1.04 63.1 >99
C2MIM·Tf2N/buffer 25 1.21 71.6 >99
C4MIM·Tf2N/buffer 44 1.08 64.7 >99
Reaction conditions: 12 mM TMSB, IL/TEA-HCl buffer (100 mM, pH 5.0) volume ratio of 1/2, 98 mM 2-propanol, 0.15 g/mL cell-loaded alginate 
beads, 30°C, 180 r/min.
a Initial reaction rate (Vo) is defined as the initial rate of the product formation in the total reaction system, expressed as the specific activity in μmol 
product per min per gram of cell wet mass (cwm) unless specified otherwise.
b Maximum yield.
c Product e.e.
d Data taken from Zhang et al [10].BMC Biotechnology 2009, 9:90 http://www.biomedcentral.com/1472-6750/9/90
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biphasic systems, the cell viability in the presence of sub-
strate was much lower in the aqueous monophasic sys-
tem, which is in good accordance with the higher initial
specific reaction rate and yield in the presence of most of
the tested ILs (CnMIM·PF6, n  = 4-7; C2MIM·Tf2N), as
compared to the aqueous system (Table 1). It was noted
that the biphasic system containing iC4MIM·PF6  or
C4MIM·Tf2N gave a slightly lower initial reaction rate
than the aqueous system, but afforded a clearly higher
yield. Higher partition coefficients of TMSB and TMSBOL
between IL and buffer could effectively reduce the toxic
effect of the substrate and/or the product on the cells as
well as the pronounced inhibitions of the reaction by the
substrate and the product observed in aqueous monopha-
sic system [10]. To better understand the toxic or inhibi-
tory effects of the product in the various IL-based biphasic
systems, the deactivation profiles of the cells in different
media in the presence of 12 mM TMSBOL product were
investigated (Fig. 3). After incubation in the aqueous sys-
tem with substrate for 1 h and 15 h, the cells retained only
58% and 17%, respectively, of their original activity,
clearly showing the severe toxic or inhibitory effect of the
product. However, the cells in IL-based biphasic systems
retained much higher relative activity (as compared to the
cells in the aqueous monophasic system) after incubation
for a same period. Among the seven water-immiscible ILs
tested in the biphasic reaction system, in all cases decreas-
ing rate of inactivation of the biocatalyst correlated with
increasing product IL/aqueous buffer partition coefficient.
This observation suggests that a major factor in determin-
ing the stability of the biocatalytic activity of the cells is
extraction of the toxic reaction product into the IL phase.
The biphasic system containing C4MIM·PF6 was most
effective in preserving the activity of the biocatalyst and
contained the IL with the highest product IL/aqueous
buffer partition coefficient. In addition to the likely toxic
effect of the product, the data in Fig. 2 suggest that the
substrate also is toxic to the cells in the presence of ILs.
In the case of the Tf2N- -based ILs (C2MIM·Tf2N and
C4MIM·Tf2N), the initial reaction rate and the maximum
yield decrease with increasing alkyl chain, showing a sim-
ilar trend to that observed with CnMIM·PF6 (n = 4-7). The
partition coefficients of TMSB and TMSBOL in the
C2MIM·Tf2N/buffer biphasic system are higher than the
corresponding values in the C4MIM·Tf2N/buffer biphasic
system (Table 2), which is consistent with the observation
that in the presence of substrate the cell viability is some-
what higher in the C2MIM·Tf2N-contianing system than
in that containing C4MIM·Tf2N (Fig. 2). Also, it should be
Table 2: Partition coefficients of TMSB and TMSBOL between 
the two phases
Biphasic system Partition coefficients
TMSB TMSBOL
C4MIM·PF6/buffer 56.3 26.2
C5MIM·PF6/buffer 55.7 25.1
C6MIM·PF6/buffer 54.2 24.4
C7MIM·PF6/buffer 53.7 23.8
iC4MIM·PF6/buffer 50.9 21.6
C2MIM·Tf2N/buffer 53.4 23.1
C4MIM·Tf2N/buffer 51.1 20.3
Cell viability of Candida parapsilosis CCTCC M203011 Figure 2
Cell viability of Candida parapsilosis CCTCC 
M203011. The cells were exposed for 12 h to various bipha-
sic systems consisting of water-immiscible ILs and TEA-HCl 
buffer (100 mM, pH 5.0) (IL/buffer volume ratio: 1/2) or 
aqueous buffer (100 mM, pH 5.0), with and without substrate 
(12 mM TMSB).
Deactivation profiles of the cells in the presence of product  in various IL-based biphasic systems Figure 3
Deactivation profiles of the cells in the presence of 
product in various IL-based biphasic systems. In each 
case, the 100% relative activity corresponded to the initial 
activity of the cells.BMC Biotechnology 2009, 9:90 http://www.biomedcentral.com/1472-6750/9/90
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noted that in the absence of substrate, C4MIM·Tf2N is less
toxic to the microbial cells than C2MIM·Tf2N (Fig. 2).
Conversely, the higher partition coefficients of TMSB and
TMSBOL with C2MIM·Tf2N (relative to C4MIM·Tf2N)
will tend to favor an efficient reduction reaction by dimin-
ishing the concentrations of the substrate and product in
the aqueous phase and thus reducing their inhibitory
effects on the cells. This is the reason that the initial reac-
tion rate and the yield achieved with the C2MIM·Tf2N-
based biphasic system were better than those with the sys-
tem containing C4MIM·Tf2N (Table 1), even though the
former IL is marginally more toxic to the cells. Addition-
ally, the biocatalytic reduction proceeded more slowly in
the presence of C4MIM·Tf2N than in the presence of
C4MIM·PF6, showing that the nature of the anion in the
ILs has a significant effect on the bioreduction. It was
worth noting that the initial reaction rate and the maxi-
mum yield clearly went down when the n-butyl group
attached to the imidazolium cation of C4MIM·PF6 was
replaced by iso-butyl (iC4MIM·PF6). This suggests that the
variation of IL structure also exerts a substantial impact on
the bioreduction. Interestingly, this minor change of IL
structure from C4MIM·PF6 to iC4MIM·PF6 also led to a
decline in the cell viability (Fig. 2) and a fall in the parti-
tion coefficients of substrate and product between the IL
phase and the aqueous phase (Table 2), which coincides
with the clearly poorer catalyst performance achieved in
the  iC4MIM·PF6-buffer biphasic system. Moreover, the
specific reaction rate (1.04-1.56 μmol/min gcwm) in the IL-
based biphasic systems examined was comparable to or
higher than that in the aqueous monophasic system (1.18
μmol/min gcwm), and the maximum yield (63.1-85.0%)
was much higher than that in the aqueous monophasic
system (33.6%) under the same reaction conditions. This
superior performance of the biocatalyst in the IL-contain-
ing system is probably due to the markedly reduced toxic
effect of the substrate to the cells, limited substrate cleav-
age, and product and/or substrate inhibition, since the ILs
effectively extract substrate and product from the aqueous
phase. As depicted in Fig. 2, in the absence of substrate,
the cell viability was lower in all tested IL-based biphasic
systems, compared to the aqueous monophasic system.
This indicates that the ILs were toxic to the cells to some
extent. Among all the water-immiscible ILs tested, the IL
C4MIM·PF6 afforded the highest cell viability (94%) (Fig.
2) and the highest partition coefficients for TMSB and
TMSBOL (Table 1), and therefore the highest yield and
specific reaction rate were observed in the C4MIM·PF6-
based biphasic system. Clearly, C4MIM·PF6 was the best
second phase for the bioreduction.
For a better understanding of the bioreduction performed
in the biphasic system containing C4MIM·PF6, the effects
of several key influential variables on the reaction were
studied. In our previous reports, it has been demonstrated
that the effect of volume ratio of the two phases on biocat-
alytic reactions varies widely and unpredictably [22,25].
As shown in Fig. 4, the volume ratio of the aqueous phase
to the IL phase (Vaq/VIL, mL/mL) substantially affected the
initial reaction rate and the maximum yield, but had no
appreciable effect on the product e.e. The obvious
enhancement in the initial reaction rate and the maxi-
mum yield with the increase of Vaq/VIL up to 4/1 suggests
inactivation of the catalytic activity of the cells that is less
pronounced as the proportion of IL in the mixture
decreases over this range. Enzymes and active cells are
often inactivated by direct contact with the interface
between the aqueous and non-aqueous phases [25,33],
and if this were the case here, the increase of activity and
yield between Vaq/VIL of 1/1 and 4/1 could be due to the
decrease in the interface area of the two-liquid phase reac-
tion system and consequent decreased frequency with
which the cells would contact the interface. However,
such a phenomenon may be unlikely since the ILs showed
low toxicity to the cells (Fig. 2). A more likely possibility
is that the effects of substrate toxicity or inhibition
decrease as the rate of substrate delivery into the aqueous
phase decreases with decreasing interface area between
the phases. Further rise in the Vaq/VIL ratio (above the opti-
mal 4/1 value) led to a clear decline in the initial reaction
rate, presumably due to much lower availability of the
substrate in the aqueous phase. Another possibility is that
cell inactivation at the interface can occur because of tox-
icity of highly concentrated substrate rather than the IL
itself.
As depicted in Fig. 5A, the initial reaction rate of the biore-
duction conducted in the C4MIM·PF6-based biphasic sys-
tem markedly increased with increasing substrate
concentration up to 24 mM (based on the volume of the
IL phase), while the maximum yield showed no signifi-
cant variation. Further rise in substrate concentration
above 24 mM, however, led to a clear drop in the initial
rate and the maximum yield. The results clearly show that
the inhibitory or toxic effect of the substrate begins to
dominate if the substrate concentration added to the IL
phase is more than 24 mM, although below this threshold
it is clear that the substrate concentration in the aqueous
phase is limiting. Throughout the range of substrate con-
centrations tested the product e.e. remained above 99%.
Fig. 5B shows the significant influence of substrate con-
centration on the bioreduction carried out in the aqueous
monophasic system. When the substrate concentration
was more than 3 mM, the initial reaction rate and the
maximum yield decreased substantially with increasing
substrate concentration, showing that substrate inhibition
or toxicity occurs even if the applied substrate concentra-
tion in the aqueous monophasic system is very low (3
mM). Product inhibition also occurred in the
C4MIM·PF6-based system, because the reaction rate andBMC Biotechnology 2009, 9:90 http://www.biomedcentral.com/1472-6750/9/90
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the maximum yield decreased with increasing concentra-
tion of added product when a range of TMSBOL concen-
trations were added at the beginning of the reaction
(Table 3). However, product inhibition was less pro-
nounced in the C4MIM·PF6-based system as compared to
the aqueous system [10]. The optimal substrate concen-
tration (24 mM) in the C4MIM·PF6-based system is much
higher than that (3 mM) in the aqueous monophasic sys-
tem.
As can be seen in Fig. 6, the reaction rate of the substrate
TMSB (24 mM) reduction in the C4MIM·PF6-based
biphasic system clearly increased with increasing concen-
tration of cell-loaded alginate beads (0.10 - 0.25 g/mL,
based on the volume of the aqueous phase). Therefore, it
could be concluded that there is no clear mass transfer
limitation over the two-phase boundary under the above-
mentioned reaction conditions.
Fig. 7 illustrates the significant effect of buffer pH in the
C4MIM·PF6/buffer biphasic system on the bioreduction
and shows that the optimal buffer pH for the reaction was
pH 5.5. Throughout the range of buffer pH tested, the
product e.e. remained above 99%.
Coenzyme recycling is one of the most important issues
encountered in biocatalytic reduction reactions. Bioreduc-
tion reactions can proceed effectively with whole cells
without adding expensive coenzymes only if a co-sub-
strate is present for recycling of the coenzyme [34]. There-
fore several commonly-employed co-substrates (2-
propanol, ethanol, glucose, mannitol) were tested. As
shown in Fig. 8, although TMSB could be reduced without
adding co-substrates into the reaction system (control),
the maximum yield was only 25.6%. Adding any single
co-substrate markedly improved the bioreduction, with 2-
propanol giving the highest activity. It has been reported
that, in addition to its role as a co-substrate, 2-propanol
might act as a permeabilizer moderately to increase the
cell membrane permeability [35], and thus allow sub-
strate and product to pass more quickly in and out of cells,
thus accelerating the bioreduction reaction. As is evident
from the data shown in Table 4, the initial reaction rate
and the maximum yield increased with increasing 2-pro-
panol concentration up to 130 mM, beyond which further
rise in 2-propanol concentration resulted in a clear
decrease in the initial reaction rate and the maximum
yield, possibly because of the negative effects of the exces-
sive 2-propanol on the cells. To test this possibility, the
viability of Candida parapsilosis CCTCC M203011 cells was
assayed after 12 h exposure to the biphasic systems con-
taining various concentrations of 2-propanol. As
expected, cell viability showed no appreciable decline
with increasing 2-propanol concentration up to 130 mM.
However, further rise in 2-propanol concentration led to
a rapid loss of cell viability (Fig. 9). The 2-propanol con-
centration showed little influence on the product e.e.,
which remained above 99% within the range tested. Thus,
the optimal concentration of 2-propanol for the reaction
was 130 mM.
As can be seen in Fig. 10, the specific reaction rate
increased with increasing reaction temperature up to
35°C, while the maximum yield clearly decreased above
30°C, owing to the inactivation of the cells that had been
incubated for a prolonged period at a higher temperature.
The product e.e. remained above 99% within the tested
range. In terms of maximising reaction rate, the reaction
Effect of volume ratio of buffer to IL on the biocatalytic  reduction of TMSB with immobilized Candida parapsilosis  CCTCC M203011 cells Figure 4
Effect of volume ratio of buffer to IL on the biocata-
lytic reduction of TMSB with immobilized Candida 
parapsilosis CCTCC M203011 cells. Reaction conditions: 
12 mM TMSB, 0.5 mL of C4MIM·PF6, various volumes of 
TEA-HCl buffer (100 mM, pH 5.0), 98 mM 2-propanol, 0.15 
g/mL cell-loaded alginate beads, 30°C, 180 r/min. Symbols: 
(❍) product e.e.; () maximum yield; (Δ) initial reaction rate.
Table 3: Effect of TMSBOL addition on the bioreduction 
conducted in C4 MIM·PF6/buffer biphasic system
Addition of
TMSBOL (mM)
Vo
(μmol/min gcwm)
Yielda
(%)
e.e.b
(%)
02 . 1 8 8 9 . 6 > 9 9
31 . 8 8 8 4 . 5 > 9 9
61 . 6 7 7 8 . 1 > 9 9
12 1.34 68.8 >99
24 0.75 33.7 >99
Reaction conditions: 24 mM TMSB, C4MIM·PF6/TEA-HCl buffer (100 
mM, pH 5.0) volume ratio of 1/4, 98 mM 2-propanol, 0.15 g/mL cell-
loaded alginate beads, 30°C, 180 r/min.
a Maximum yield.
b Product e.e.BMC Biotechnology 2009, 9:90 http://www.biomedcentral.com/1472-6750/9/90
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Effect of substrate concentration on the biocatalytic reduction of TMSB with immobilized Candida parapsilosis CCTCC  M203011 cells in the C4MIM·PF6-based system (A) and in the aqueous system (B) Figure 5
Effect of substrate concentration on the biocatalytic reduction of TMSB with immobilized Candida parapsilosis 
CCTCC M203011 cells in the C4MIM·PF6-based system (A) and in the aqueous system (B). Reaction conditions: 
(A): various concentrations of TMSB, C4MIM·PF6/TEA-HCl buffer (100 mM, pH 5.0) volume ratio of 1/4 (0.5 mL/2.0 mL), 98 
mM 2-propanol, 0.15 g/mL cell-loaded alginate beads, 30°C, 180 r/min; (B): various concentrations of TMSB, TEA-HCl buffer (4 
mL, 100 mM, pH 5.0), 98 mM 2-propanol, 0.15 g/mL cell-loaded alginate beads, 30°C, 180 r/min. Symbols: (❍) product e.e.; () 
maximum yield; (Δ) initial reaction rate.
Effect of biocatalyst concentration on the biocatalytic reduc- tion of TMSB with immobilized Candida parapsilosis CCTCC  M203011 cells Figure 6
Effect of biocatalyst concentration on the biocata-
lytic reduction of TMSB with immobilized Candida 
parapsilosis CCTCC M203011 cells. Reaction conditions: 
24 mM TMSB, C4MIM·PF6/TEA-HCl buffer (100 mM, pH 5.0) 
volume ratio of 1/4, 98 mM 2-propanol, various concentra-
tions of cell-loaded alginate beads (based on the volume of 
the aqueous phase), 30°C, 180 r/min.
Effect of buffer pH on the biocatalytic reduction of TMSB  with immobilized Candida parapsilosis CCTCC M203011 cells Figure 7
Effect of buffer pH on the biocatalytic reduction of 
TMSB with immobilized Candida parapsilosis CCTCC 
M203011 cells. Reaction conditions: 24 mM TMSB, 
C4MIM·PF6/TEA-HCl buffer (100 mM, various pHs) volume 
ratio of 1/4, 98 mM 2-propanol, 0.15 g/mL cell-loaded algi-
nate beads, 30°C, 180 r/min. Symbols: (❍) product e.e.; () 
maximum yield; (Δ) initial reaction rate.BMC Biotechnology 2009, 9:90 http://www.biomedcentral.com/1472-6750/9/90
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yield and the product e.e., 30°C was concluded to be as
the most suitable temperature for the reaction.
Fig. 11 depicts the time-course of the bioreduction of
TMSB with immobilized Candida parapsilosis CCTCC
M203011 cells in the C4MIM·PF6-based biphasic system
under the above-described optimum conditions. The reac-
tion rate decreased relatively slowly with reaction time in
the C4MIM·PF6-based system as compared to the aqueous
system [10], almost certainly due to the in situ extraction
of substrate and product into the IL phase. Therefore, the
reaction efficiency was substantially enhanced with
C4MIM·PF6 as compared to the aqueous system and the
yield was increased from 81.3% with the aqueous system
[10] to 97.7% in the IL-containing system. The product
e.e. remained above 99% in both reaction systems.
To show the applicability of the biocatalytic reduction of
TMSB to (S)-TMSBOL using immobilized Candida parapsi-
losis  CCTCC M203011 cells in the C4MIM·PF6-based
biphasic system, we also carried out the bioreduction on
a 250-mL preparative scale under the optimal reaction
conditions detailed above, i.e. 24 mM TMSB,
C4MIM·PF6/TEA-HCl buffer (100 mM, pH 5.5) volume
ratio of 1/4 (50 mL/200 mL), 130 mM 2-propanol, 0.15
g/mL cell-loaded alginate beads, 30°C, 180 r/min. The
reaction process was monitored by GC analysis and the
product was extracted from the reaction mixture with n-
Table 4: Effect of co-substrate concentration on the bioreduction
2-Propanol concentration (mM) Vo
(μmol/min gcwm)
Yielda
(%)
e.e.b
(%)
00 . 9 5 2 5 . 6 > 9 9
34 1.57 72.9 >99
66 1.99 85.1 >99
98 2.30 92.8 >99
130 2.46 97.7 >99
162 2.22 90.5 >99
194 1.88 80.3 >99
258 1.07 50.4 >99
Reaction conditions: 24 mM TMSB, C4MIM·PF6/TEA-HCl buffer (100 mM, pH 5.5) volume ratio of 1/4, various concentrations of 2-propanol, 0.15 g/
mL cell-loaded alginate beads, 30°C, 180 r/min.
a Maximum yield.
b Product e.e.
Effect of various co-substrates on the biocatalytic reduction  of TMSB with immobilized Candida parapsilosis CCTCC  M203011 cells Figure 8
Effect of various co-substrates on the biocatalytic 
reduction of TMSB with immobilized Candida parap-
silosis CCTCC M203011 cells. Reaction conditions: 24 
mM TMSB, C4MIM·PF6/TEA-HCl buffer (100 mM, pH 5.5) 
volume ratio of 1/4, different co-substrates (98 mM), 0.15 g/
mL cell-loaded alginate beads, 30°C, 180 r/min. The relative 
activity of the cells without any co-substrates was defined as 
100%.
Cell viability of Candida parapsilosis CCTCC M203011 in the  presence of 2-propanol Figure 9
Cell viability of Candida parapsilosis CCTCC M203011 
in the presence of 2-propanol. The cells were exposed 
for 12 h to the medium containing various concentrations of 
2-propanol.BMC Biotechnology 2009, 9:90 http://www.biomedcentral.com/1472-6750/9/90
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hexane upon the exhaustion of the substrate. The biore-
duction behavior was similar to that shown in Fig. 11.
Although slightly lower than that obtained on the 2.5-mL
scale, the isolated yield (95.9%) after reaction for 15 h on
the 250-mL scale was much higher than that achieved in
aqueous system [9,10], and the product e.e. was excellent
(>99%). Furthermore, no emulsification of the IL-based
biphasic system was observed, so the phases could be sep-
arated readily by centrifugation. No by-products accumu-
lated in the IL phase, and the IL could be easily recycled,
reducing the overall cost of the biocatalytic process. Hence
the whole-cell biocatalytic reduction of TMSB to (S)-
TMSBOL on a preparative scale in the C4MIM·PF6-based
biphasic system is a promising and competitive reaction.
The operational stability of the biocatalyst was also inves-
tigated in the C4MIM·PF6-based biphasic system, in com-
parison with the aqueous system. As depicted in Fig. 12,
after being used repeatedly for 1 batch (12 h per batch) in
the presence of C4MIM·PF6, the immobilized cells
retained around 99% of their original activity, which was
much higher than that in the aqueous system (34%) dur-
ing the same operation period (12 batches, 1 h per batch).
Furthermore, the immobilized cells still retained more
than 83% of their initial activity even after being used
repeatedly for 12 batches in the C4MIM·PF6-based bipha-
sic system. Hence it is clear that C4MIM·PF6 considerably
enhances the operational stability of the cells. This
enhancement of the operational stability of the cells may
be due to the very good biocompatibility of C4MIM·PF6
Effect of reaction temperature on the biocatalytic reduction  of TMSB with immobilized Candida parapsilosis CCTCC  M203011 cells Figure 10
Effect of reaction temperature on the biocatalytic 
reduction of TMSB with immobilized Candida parap-
silosis CCTCC M203011 cells. Reaction conditions: 24 
mM TMSB, C4MIM·PF6/TEA-HCl buffer (100 mM, pH 5.5) 
volume ratio of 1/4, 130 mM 2-propanol, 0.15 g/mL cell-
loaded alginate beads, various temperatures, 180 r/min. Sym-
bols: (❍) product e.e.; () maximum yield; (Δ) initial reaction 
rate.
Time-course profile of the biocatalytic reduction of TMSB  with immobilized Candida parapsilosis CCTCC M203011 cells  in C4MIM·PF6/buffer biphasic system Figure 11
Time-course profile of the biocatalytic reduction of 
TMSB with immobilized Candida parapsilosis CCTCC 
M203011 cells in C4MIM·PF6/buffer biphasic system. 
Reaction conditions: 24 mM TMSB, C4MIM·PF6/TEA-HCl 
buffer (100 mM, pH 5.5) volume ratio of 1/4, 130 mM 2-pro-
panol, 0.15 g/mL cell-loaded alginate beads, 30°C, 180 r/min.
Operational stability of immobilized Candida parapsilosis  CCTCC M203011 cells Figure 12
Operational stability of immobilized Candida parapsi-
losis CCTCC M203011 cells. Reaction conditions with 
C4MIM·PF6/buffer biphasic system: 24 mM TMSB, C4MIM·PF6/
TEA-HCl buffer (100 mM, pH 5.5) volume ratio of 1/4, 130 
mM 2-propanol, 0.15 g/mL immobilized cells, 30°C, 180 r/
min, 12 h per batch. Reaction conditions with aqueous sys-
tem: 3 mM TMSB, 2.5 mL of TEA-HCl buffer (100 mM, pH 
5.0), 65.3 mM 2-propanol, 0.15 g/mL cell-loaded alginate 
beads, 30°C, 180 r/min, 1 h per batch. The relative activity of 
the immobilized cells in the first batch was defined as 100%.BMC Biotechnology 2009, 9:90 http://www.biomedcentral.com/1472-6750/9/90
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and its excellent ability to extract toxic substrate and prod-
uct from the aqueous phase. The cells maybe also become
coated with the IL and thus protected from the inactiva-
tion. In addition, the interactions between the IL and the
carrier (calcium alginate) used for immobilization of the
cells could contribute to the good stability of the cells in
the C4MIM·PF6-based biphasic system.
Conclusion
The synthesis of (S)-TMSBOL can be successfully con-
ducted with high yield and excellent product e.e. by means
of the biocatalytic asymmetric reduction of TMSB using
immobilized Candida parapsilosis CCTCC M203011 cells
in water-immiscible IL-based biphasic systems. Various
ILs exerted significant but different influences on the
bioreduction. Of all the examined ILs, C4MIM·PF6 was
most effective for the bioreduction. The optimal substrate
concentration (24 mM vs 3 mM) and the yield (97.7% vs
81.3) were substantially enhanced in the C4MIM·PF6-
based system compared to the aqueous system, and the
cells also retained a much higher relative activity in the
C4MIM·PF6-based system than that in the aqueous sys-
tem after being employed repeatedly for 12 batches (83%
vs 34%), showing the excellent operational stability in the
presence of C4MIM·PF6. The good performance of the
biocatalyst in the presence of the IL may be due to the IL's
excellent solvent properties for substrate and product and
its good biocompatibility with the cells. Furthermore, the
results described here clearly show that the whole-cell bio-
catalytic process in the presence of C4MIM·PF6 is feasible
up to a 250-mL scale. If further scale-up is possible, the
reaction will be attractive for large-scale industrial applica-
tion.
Methods
Biological and chemical materials
Candida parapsilosis CCTCC M203011 was kindly donated
by Professor Yan Xu (Key Laboratory of Industrial Bio-
technology of Ministry of Education and School of Bio-
technology, Southern Yangtze University, China).
4-(Trimethylsilyl)-3-butyn-2-one (TMSB, 97% purity), 4-
(trimethylsilyl)-3-butyn-2-ol (TMSBOL, 97% purity) and
n-decane (>99% purity) were purchased from Sigma-
Aldrich (USA). The seven water-immiscible ILs used in
this work, 1-butyl-3-methylimidazolium hexafluorophos-
phate (C4MIM·PF6), 1-pentyl-3-methylimidazolium hex-
afluorophosphate (C5MIM·PF6), 1-hexyl-3-
methylimidazolium hexafluorophosphate (C6MIM·PF6),
1-heptyl-3-methylimidazolium hexafluorophosphate
(C7MIM·PF6), 1-isobutyl-3-methylimidazolium hex-
afluorophosphate (iC4MIM·PF6), 1-ethyl-3-methylimi-
dazolium bis(trifluoromethanesulfonyl)imide
(C2MIM·Tf2N) and 1-butyl-3-methylimidazolium bis(tri-
fluoromethanesulfonyl)imide (C4MIM·Tf2N) were from
Lanzhou Institute of Chemical Physics (China) and were
all of over 97% purity. All other chemicals were obtained
from commercial sources and were of analytical grade.
Cultivation and immobilization of Candida parapsilosis 
CCTCC M203011 cells
Candida parapsilosis CCTCC M203011 cells were cultivated
and immobilized as described in [10].
General procedure for the bioreduction of TMSB to (S)-
TMSBOL
In a typical experiment, the biphasic system (2.5 mL) con-
sisted of a water-immiscible IL and TEA-HCl buffer (100
mM, various pHs: 4.0-7.0), contained in a 20-mL Erlen-
meyer flask capped with a septum. Alginate beads were
prepared that were loaded with 31% (w/w) Candida parap-
silosis  CCTCC M203011 cells {based on cell wet mass
(cwm)}and 0.15 g of these cell-loaded alginate beads
were added per mL of the aqueous phase, together with a
predetermined quantity of co-substrate (0-258 mM based
on the total volume of a biphasic system). The reaction
mixture was pre-incubated in a water-bath shaker at 180
r/min and various temperatures (20-45°C) for 15 min.
Then, the reactions were initiated by adding TMSB at var-
ious concentrations (3-36 mM, based on the volume of
the IL phase). Aliquots (10 μL) were withdrawn at speci-
fied time intervals from the IL phase and the aqueous
phase, respectively, and the product as well as the residual
substrate was extracted with n-hexane (50 μL) containing
5.1 mM n-decane (as an internal standard), prior to GC
analysis. Details of the IL used, volume ratio of buffer to
IL, substrate concentration, buffer pH, co-substrate and its
concentration and reaction temperature are specified for
each case. Throughout this paper, unless specified other-
wise, applied substrate concentration refers to that in the
IL phase of a biphasic system and the co-substrate concen-
tration is given for the total volume of a biphasic system.
Cell viability assay
The viability of Candida parapsilosis CCTCC M203011 cells
was assayed after incubating the alginate-immobilized
cells for 12 h in various biphasic systems consisting of
water-immiscible ILs and TEA-HCl buffer (100 mM, pH
5.0) (IL/buffer volume ratio: 1/2), or TEA-HCl buffer (100
mM, pH 5.0) system, without substrate and with substrate
(12 mM TMSB, based on the volume of the IL phase),
respectively. The beads containing the immobilized cells
were withdrawn from the reaction systems and then
added to 0.1 M trisodium citrate to dissolve the alginate.
After this, the microbial cell suspension was diluted and
stained with 0.1% Methylene Blue for 5 min [25,29].
Microscopic pictures were taken and analyzed for blue
dead cells and colorless viable ones.BMC Biotechnology 2009, 9:90 http://www.biomedcentral.com/1472-6750/9/90
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Determination of partition coefficients
Partition coefficients (KIL/aq) were determined by dissolv-
ing 12, 24 or 36 mM TMSB or TMSBOL, as appropriate, in
each IL/buffer biphasic system (IL/buffer volume ratio: 1/
2) and shaking (180 r/min) for 40 h at 30°C. The concen-
trations of TMSB or TMSBOL in the IL phase and the aque-
ous phase were then analyzed by GC. The concentration
of TMSB or TMSBOL in each phase varied linearly with the
total amount of each chemical added to the two-phase
system. Then the slopes were calculated and used for the
quantification of the partition coefficients of TMSB and
TMSBOL between the IL phase and the aqueous phase.
Operational stability of immobilized Candida parapsilosis 
CCTCC M203011 cells
In order to assess the operational stability of the cells, the
re-use of the immobilized Candida parapsilosis CCTCC
M203011 cells was investigated in the C4MIM·PF6/buffer
biphasic system and also in the aqueous monophasic sys-
tem. Initially, aliquots of the cells were added into sepa-
rate screw-capped vials each containing 2.5 mL of the
appropriate medium {C4MIM·PF6/TEA-HCl buffer (100
mM, pH 5.5) biphasic system (volume ratio: 1/4), or
aqueous TEA-HCl buffer system (100 mM, pH 5.0)},
together with the optimal amount of TMSB and 2-propa-
nol for the reduction conducted in the various media.
Then, the bioreductions were carried out at 30°C and 180
r/min and were repeated over 12 batches without chang-
ing the immobilized cells. Between batches, the immobi-
lized cells were filtered off from the reaction mixture,
washed twice with fresh water, and added to a fresh batch
of reaction medium. The reduction activity of the cells was
assayed in each batch. The relative activity of the cells
employed for the first batch was defined as 100%.
GC analysis
Reaction mixtures were analyzed according to the GC
analysis method previously reported [10]. The retention-
times for TMSB, n-decane and TMSBOL were 5.1, 5.7, and
10.5 min, respectively. Also, the product configuration
was confirmed to be (S)-TMSBOL [10]. The average error
for this determination was less than 1.0%. All reported
data were averages of experiments performed at least in
duplicate.
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